Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

@article{Johnson2019ClassicPA,
  title={Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function},
  author={Matthew W. Johnson and Peter S. Hendricks and Frederick Streeter Barrett and Roland R. Griffiths},
  journal={Pharmacology \& Therapeutics},
  year={2019},
  volume={197},
  pages={83–102}
}
New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances
TLDR
This research primarily investigates the potential of psychedelics in the treatment of mental health disorders, their short- and long-term effects on recreational users, and the neurological and cognitive processes responsible for their effects.
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
TLDR
This work aims to be a reference for psychiatrists who may soon be faced with the possibility of prescribing psychedelic compounds as medications, helping them assess which compound(s) and regimen could be most useful for decreasing specific psychiatric symptoms.
The Psychedelic Renaissance and Its Forensic Implications
  • B. Holoyda
  • Medicine, Psychology
    The Journal of the American Academy of Psychiatry and the Law
  • 2020
TLDR
Basic information that the forensic practitioner should know about psychedelic substances, including their various effects and proposed mechanism of action are summarized; historical and recent research into psychedelics and criminal behavior are described; and a practical means by which to assess individuals' psychedelic use in forensic contexts is offered.
Natural Language as a Window into the Subjective Effects and Neurochemistry of Psychedelic Drugs
Psychedelics are drugs capable of eliciting profound alterations in the subjective experience of the users, sometimes with long-lasting consequences. Because of this, psychedelic research tends to
Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?
TLDR
Three articles rise the fundamental question of mechanism behind therapeutic effects of hallucinogenic and entactogenic substances, which patients might benefit from these treatments and which might not, how therapeutic effects can be promoted and risks further minimized.
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.
TLDR
The strength of the effect sizes, fast onset, and enduring therapeutic effects of these psychotherapeutic agents encourage further double-blind, placebo-controlled clinical trials assessing them for management of negative mood and depressive symptoms.
The Potential Role of Serotonergic Hallucinogens in Depression Treatment
TLDR
The reviewed studies suggest that psychedelics have great potential in depression therapy and, after addressing and overcoming the current study limitations, may be used as a novel method of treating depression in the future.
Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy
The use of psychedelics in a therapeutical setting has been reported for the treatment of various diagnoses in recent years. However, as psychedelic substances are still commonly known for their
Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.
TLDR
Analysis of areas of overlap between SP and ketamine research suggests a potentially shared mechanism wherein both ketamine and SPs may engender rapid neuroplastic effects in a glutamatergic activity-dependent manner.
A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties
TLDR
Preliminary evidence for a role of the psychedelic experience and afterglow in ketamine’s antidepressant properties is provided and Reflexive thematic analysis provided a wealth of information on participants’ experience and demonstrated the psychedelic properties of ketamine are not fully captured by commonly used questionnaires.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 303 REFERENCES
Psychiatry might need some psychedelic therapy
TLDR
Promising therapeutic applications were investigated, with particularly promising findings in the treatment of both addiction and cancer-related psychiatric existential distress, however, despite initial excitement, research on these drugs became increasingly marginalized due to their growing use outside of clinical research settings, and their resulting association with the counter-culture movement in the late 1960s and early 1970s.
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
TLDR
This review aims to re-evaluate earlier and recent concepts of how psychedelic substances may exert beneficial effects, and summarizes evidence for the relationship between subjective experiences and therapeutic success.
Potential Therapeutic Effects of Psilocybin
Psilocybin and other 5-hydroxytryptamine2A agonist classic psychedelics have been used for centuries as sacraments within indigenous cultures. In the mid-twentieth century they were a focus within
Psychedelics
TLDR
Blood oxygen level–dependent functional magnetic resonance imaging and magnetoencephalography have been employed for in vivo brain imaging in humans after administration of a psychedelic, and results indicate that intravenously administered psilocybin and LSD produce decreases in oscillatory power in areas of the brain’s default mode network.
Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.
TLDR
A functional neural model of mystical experience is proposed, based on changes in the default mode network of the brain that have been observed after the administration of classic hallucinogens and during meditation practices for which mystical-type claims have been made.
Phenomenology, Structure, and Dynamic of Psychedelic States.
TLDR
This review outlines contemporary approaches to characterize the structure of ASCs by means of three primary etiology-independent dimensions including oceanic boundlessness, anxious ego-dissolution, and visionary restructuralization as well as by 11 lower-order factors, all of which can be reliably measured by the altered state of consciousness questionnaire.
Treatment of alcoholism using psychedelic drugs: a review of the program of research.
  • M. Mangini
  • Psychology, Medicine
    Journal of psychoactive drugs
  • 1998
TLDR
The history of one branch of psychedelic research, the therapeutic use of LSD in the treatment of alcoholism, and of the events that led to the relabeling of the "hallucinogens" as drugs of abuse are explored.
Neural correlates of the LSD experience revealed by multimodal neuroimaging
TLDR
Three complementary neuroimaging techniques, implemented during resting state conditions, revealed marked changes in brain activity after LSD that correlated strongly with its characteristic psychological effects, contributing important new insights into the characteristic hallucinatory and consciousness-altering properties of psychedelics.
Implications of LSD and experimental mysticism
TLDR
The need soberly to consider the potential dangers and values inherent in this field of research from theological, psychiatric, and societal perspectives has become crucial in the light of this complex controversy.
Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations
TLDR
These results provide systematic evidence for the direct association of a specific spatiotemporal neuronal mechanism with spiritual experiences and enhanced insight into life and existence and may constitute a pathway for modulating mental health.
...
1
2
3
4
5
...